NewEdge Advisors, LLC

Position in OGN — Organon & Co.

CIK 1633516 NEW ORLEANS, LA

Position in OGN

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$16,911

+$3,242 QoQ

Shares Held

1,249

-45.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#326

of 626 holders

Holding Since

Dec 2021

16 quarters on record

Voting authority Sole 2% Shared 0% None 98%

Healthcare · as of Jun 30, 2026

NewEdge Advisors, LLC holds $832,318,596 across 17 Drug Manufacturers - General names. OGN ranks #16 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	194,721	$233,554,228
2	JNJ	Johnson & Johnson	917,872	$233,111,951
3	ABBV	AbbVie Inc.	439,164	$110,511,228
4	MRK	Merck & Co., Inc.	455,515	$58,533,677
5	GILD	Gilead Sciences, Inc.	442,389	$55,891,426
6	GSK	GSK plc	953,574	$49,986,349
7	AMGN	Amgen Inc	93,040	$33,691,644
8	PFE	Pfizer Inc	687,769	$16,561,477

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$16,911	1,249	-45.3%	Shares	Sole	2026-08-12
2026-03-31	$13,669	2,282	-0.2%	Shares	Sole	2026-06-03
2025-12-31	$16,397	2,287	+112.2%	Shares	Sole	2026-02-18
2025-09-30	$11,513	1,078	-19.6%	Shares	Sole	2025-11-17
2025-06-30	$12,980	1,341	-9.3%	Shares	Sole	2025-08-14
2025-03-31	$22,022	1,479	-3.8%	Shares	Sole	2025-05-15
2024-12-31	$22,932	1,537	-2.1%	Shares	Sole	2025-02-13
2024-09-30	$30,034	1,570	+1.2%	Shares	Sole	2024-11-14
2024-06-30	$32,126	1,552	-2.1%	Shares	Sole	2024-08-16
2024-03-31	$29,816	1,586	-8.9%	Shares	Sole	2024-05-14
2023-12-31	$25,105	1,741	-22.3%	Shares	Sole	2024-02-13
2023-09-30	$38,886	2,240	+31.1%	Shares	Sole	2023-11-14
2023-06-30	$35,543	1,708	-9.5%	Shares	Sole	2023-08-14
2023-03-31	$44,382	1,887	-59.9%	Shares	Sole	2023-05-12
2022-12-31	$131,382	4,704	-77.2%	Shares	Sole	2023-02-14
2021-12-31	$627,635	20,612	—	Shares	Sole	2022-02-17
No filing history on record for this holder in this stock.